Rigel Pharmaceuticals Inc vs ASML Holding NV
A head-to-head of Rigel Pharmaceuticals Inc (RIGL) and ASML Holding NV (ASMLF) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | RIGL | ASMLF |
|---|---|---|
| Market Cap | $564.75M | $541.44B |
| P/E (TTM) | 1.50 | 44.97 |
| Forward P/E | 6.45 | 40.16 |
| P/S | 1.92 | 16.07 |
| P/B | 1.41 | 22.44 |
| EV/EBITDA | 3.51 | 38.65 |
| Dividend Yield | — | 0.55% |
| Profit Margin | 124.72% | 30.86% |
| Gross Margin | 93.33% | 52.83% |
| Operating Margin | 42.63% | 34.60% |
| Revenue Growth (YoY) | +21.19% | +13.25% |
| FCF Yield | 13.40% | 1.65% |
| Debt / Equity | 13.51 | 12.99 |
| Current Ratio | 2.42 | 1.36 |
Share:
Compare Rigel Pharmaceuticals Inc with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.